title: Activation of PPARdelta alters lipid metabolism in db/db mice.
abstract: Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors, which heterodimerize with the retinoid X receptor and bind to peroxisome proliferator response elements in the promoters of regulated genes. Despite the wealth of information available on the function of PPARalpha and PPARgamma, relatively little is known about the most widely expressed PPAR subtype, PPARdelta. Here we show that treatment of insulin resistant db/db mice with the PPARdelta agonist L-165041, at doses that had no effect on either glucose or triglycerides, raised total plasma cholesterol concentrations. The increased cholesterol was primarily associated with high density lipoprotein (HDL) particles, as shown by fast protein liquid chromatography analysis. These data were corroborated by the chemical analysis of the lipoproteins isolated by ultracentrifugation, demonstrating that treatment with L-165041 produced an increase in circulating HDL without major changes in very low or low density lipoproteins. White adipose tissue lipoprotein lipase activity was reduced following treatment with the PPARdelta ligand, but was increased by a PPARgamma agonist. These data suggest both that PPARdelta is involved in the regulation of cholesterol metabolism in db/db mice and that PPARdelta ligands could potentially have therapeutic value.
authors.affiliation: Department of Molecular Endocrinology, Merck Research Laboratories, Rahway, NJ 07065, USA. mleibowitz@ligand.com
authors.forename: M D
authors.initials: MD
authors.lastname: Leibowitz
authors.forename: C
authors.initials: C
authors.lastname: Fiévet
authors.forename: N
authors.initials: N
authors.lastname: Hennuyer
authors.forename: J
authors.initials: J
authors.lastname: Peinado-Onsurbe
authors.forename: H
authors.initials: H
authors.lastname: Duez
authors.forename: J
authors.initials: J
authors.lastname: Bergera
authors.forename: C A
authors.initials: CA
authors.lastname: Cullinan
authors.forename: C P
authors.initials: CP
authors.lastname: Sparrow
authors.forename: J
authors.initials: J
authors.lastname: Baffic
authors.forename: G D
authors.initials: GD
authors.lastname: Berger
authors.forename: C
authors.initials: C
authors.lastname: Santini
authors.forename: R W
authors.initials: RW
authors.lastname: Marquis
authors.forename: R L
authors.initials: RL
authors.lastname: Tolman
authors.forename: R G
authors.initials: RG
authors.lastname: Smith
authors.forename: D E
authors.initials: DE
authors.lastname: Moller
authors.forename: J
authors.initials: J
authors.lastname: Auwerx
mesh_terms: D000085:Acetates / Q000494:pharmacology; D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002784:Cholesterol / Q000737:chemistry / Q000378:metabolism; D002853:Chromatography, Liquid; D004268:DNA-Binding Proteins / Q000737:chemistry / Q000378:metabolism*; D008024:Ligands; D008055:Lipids / Q000097:blood*; D008071:Lipoprotein Lipase / Q000378:metabolism; D008074:Lipoproteins / Q000737:chemistry / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D010636:Phenols / Q000494:pharmacology; D010642:Phenoxyacetates; D018160:Receptors, Cytoplasmic and Nuclear / Q000737:chemistry / Q000378:metabolism*; D014157:Transcription Factors / Q000737:chemistry / Q000378:metabolism*; D014280:Triglycerides / Q000097:blood; D014461:Ultracentrifugation
chemical_list: C520164:4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid; D000085:Acetates; D001786:Blood Glucose; D004268:DNA-Binding Proteins; D008024:Ligands; D008055:Lipids; D008074:Lipoproteins; D010636:Phenols; D010642:Phenoxyacetates; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D014280:Triglycerides; D002784:Cholesterol; D008071:Lipoprotein Lipase